Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels

Ophthalmic Surgery and Lasers

Volumn 31, Issue 4, 2000, Pages 323-327

  Peyman, Gholam A ^a,b   Kazi, Abdul Ahad ^a   Moshfeghi, Darius ^a,b   Unal, Melih ^a   Khoobehi, Bahram ^a   Yoneya, Shin ^c   Mori, Keisuke ^c   Rivera, Ingrid ^a  

^a LSU EYE CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN; TALAPORFIN;

ANIMAL MODEL; ARTICLE; BLOOD VESSEL OCCLUSION; CHOROID VASCULARIZATION; FLUORESCENCE ANGIOGRAPHY; MONKEY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RABBIT; RAT; RETINA BLOOD VESSEL;

ANIMALS; CHOROID; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; INJECTIONS, INTRAVENOUS; MACACA FASCICULARIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RABBITS; RATS; RATS, LONG-EVANS; RECURRENCE; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; RETINAL VESSELS; SEVERITY OF ILLNESS INDEX;

EID: 0033868186     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hyman LG. Senile macular degeneration: An epidemiologic case-control study. Baltimore, MD: The Johns Hopkins University; 1981. Thesis.
2. Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1982;100:912-918.
3. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: three-year results from randomized clinical trials. Arch Ophthalmol. 1986;104:694-701.
4. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1990;108:816-824.
5. Macular Photocoagulation Study Group. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol. 1986;104:503-512.
6. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol. 1990;108:825-831.
7. Ciulla TA, Danis RP, Harris A. Age-related macular degeneration: a review of experimental treatments. Surv Ophthalmol. 1998;43:134-146.
8. Husain D, Miller JW, Michaud N, Connolly E, Flotte TJ, Gragoudas ES. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol. 1996;114:978-985.
9. Kliman GH, Puliafito CA, Stern D, Borirakchanyavat S, Gregory WA. Phthalocyanine photodynamic therapy: new strategy for closure of choroidal neovascularization. Lasers Surg Med. 1994;15:2-10.
10. Kramer M, Miller JW, Michaud N, et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy: selective treatment of choroidal neovascularization in monkeys. Ophthalmology. 1996;103:427-438.
11. Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol. 1995;113:810-818.
12. Peyman GA, Moshfeghi DM, Moshfeghi A, et al. Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2). Ophthalmic Surg Lasers. 1997;28:409-417.
13. Moshfeghi DM, Peyman GA, Moshfeghi AA, Khoobehi B, Primbs GB, Crean DH. Ocular vascular thrombosis following Purlytin™-photodynamic therapy: time dependencies. Ophthalmic Surg Lasers. 1998;29:663-668.
14. Miller H, Miller B. Photodynamic therapy of subretinal neovascularization in the monkey eye. Arch Ophthalmol. 1993;111:855-860.